Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on the Diagnostic Cut-off Value of Core Biomarkers in Cerebrospinal Fluid and Blood of Alzheimer's Disease

NCT05020106 is registered in ClinicalTrials.gov with Capital Medical University as lead sponsor.

NCT NCT05020106
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05020106 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on the Diagnostic Cut-off Value of Core Biomarkers in Cerebrospinal Fluid and Blood of Alzheimer's Disease
Lead sponsor
Capital Medical University
Phase
Observational
Overall status
Recruiting
Start date
September 1, 2018
Completion date
September 1, 2027
Enrollment
3,200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease